Phase 3 HNSCC Clinical Trials

5 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–5 of 5 trials

Recruiting

Phase 3

Study Comparing Ivonescimab Alone or Ivonescimab in Combination With Ligufalimab Versus Pembrolizumab for the Treatment of SCCHN

Squamous Cell Carcinoma Head and Neck Cancer (HNSCC)

Groupe Oncologie Radiotherapie Tete et Cou780 enrolled1 locationNCT07264075

Recruiting

Phase 3

Proton Versus Photon Therapy in Head and Neck Squamous Cell Carcinomas.

HNSCC

Oslo University Hospital400 enrolled4 locationsNCT07580300

Recruiting

Phase 2Phase 3

Trial Evaluating Hypo-fractionated Accelerated Versus Conventional Fractionated Adjuvant RT in Head & Neck Malignancies

Squamous Cell Carcinoma Head and Neck Cancer (HNSCC)

All India Institute of Medical Sciences369 enrolled1 locationNCT07573956

Recruiting

Phase 2Phase 3

INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC

Head and Neck Squamous Cell Carcinoma (HNSCC)

Inhibrx Biosciences, Inc410 enrolled88 locationsNCT06295731

Recruiting

Phase 3

PD-1 Inhibitor Therapy Versus Radiotherapy in pCR Patients With Locally Advanced HNSCC After Neoadjuvant Immunochemotherapy

HNSCCRadiotherapyPD-1

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University324 enrolled1 locationNCT05980715